Aldeyra Therapeutics Inc. buy me8
Start price
16.10.23
/
0%
€1.39
Target price
16.10.24
-
Performance (%)
61.90%
End price
16.10.23
€2.25
Summary
This prediction ended on 16.10.23 with a price of €2.25. With a performance of 61.90% the BUY prediction by me8 was a big success. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Aldeyra Therapeutics Inc. | 2.354% | 2.354% |
| iShares Core DAX® | 3.178% | 0.980% |
| iShares Nasdaq 100 | 2.972% | 0.925% |
| iShares Nikkei 225® | 0.545% | -4.556% |
| iShares S&P 500 | 2.367% | 0.833% |
According to me8 what are the pros and cons of Aldeyra Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Differentiated customer and product portfolio
Cons
Few uniques
Comments by me8 for this prediction
In the thread Aldeyra Therapeutics Inc. diskutieren
Buy Aldeyra Therapeutics Inc.